HashiCorp (HCP) 10-Q 7 Jun 23 2024 Q1 Quarterly report Financial data

Cover

Cover - shares	3 Months Ended
	Apr. 30, 2023	Jun. 02, 2023
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Apr. 30, 2023
Document Transition Report	false
Entity File Number	001-41121
Entity Registrant Name	HashiCorp, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	32-0410665
Entity Address, Address Line One	101 Second Street
Entity Address, Address Line Two	Suite 700
Entity Address, City or Town	San Francisco
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	94105
City Area Code	(415)
Local Phone Number	301-3250
Title of 12(b) Security	Class A Common Stock, par value $0.000015 per share
Trading Symbol	HCP
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Central Index Key	0001720671
Document Fiscal Period Focus	Q1
Amendment Flag	false
Current Fiscal Year End Date	--01-31
Document Fiscal Year Focus	2024
Common Class A
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		100,420,703
Common Class B
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		91,463,210

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Apr. 30, 2023	Jan. 31, 2023
Current assets
Cash and cash equivalents	$ 966,791	$ 1,286,134
Short-term investments	322,395	0
Accounts receivable, net of allowance of $13 for both periods	102,939	162,369
Deferred contract acquisition costs	42,995	42,812
Prepaid expenses and other current assets	26,760	17,683
Total current assets	1,461,880	1,508,998
Deferred contract acquisition costs, non-current	80,227	81,286
Other assets, non-current	41,242	38,056
Total assets	1,583,349	1,628,340
Current liabilities:
Accounts payable	13,470	12,450
Accrued expenses and other current liabilities	8,835	10,163
Accrued compensation and benefits	53,474	58,628
Deferred revenue	249,515	272,909
Customer deposits	24,890	26,699
Total current liabilities	350,184	380,849
Deferred revenue, non-current	26,899	29,335
Other liabilities, non-current	11,970	12,806
Total liabilities	389,053	422,990
Commitments and contingencies (note 8)
Stockholders’ equity
Additional paid-in capital	2,028,017	1,985,747
Accumulated other comprehensive loss	(66)	0
Accumulated deficit	(833,658)	(780,400)
Total stockholders’ equity	1,194,296	1,205,350
Total liabilities and stockholders’ equity	1,583,349	1,628,340
Class A Common Stock
Stockholders’ equity
Common Stock	1	1
Class B Common Stock
Stockholders’ equity
Common Stock	$ 2	$ 2

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands	Apr. 30, 2023	Jan. 31, 2023
Accounts receivable, allowances	$ 13	$ 13
Class A Common Stock
Common stock, par value (in dollars per share)	$ 0.000015	$ 0.000015
Common stock, shares authorized (in shares)	1,000,000,000	1,000,000,000
Common stock, shares issued (in shares)	98,358,000	88,823,000
Common stock, shares outstanding (in shares)	98,358,000	88,823,000
Class B Common Stock
Common stock, par value (in dollars per share)	$ 0.000015	$ 0.000015
Common stock, shares authorized (in shares)	200,000,000	200,000,000
Common stock, shares issued (in shares)	93,194,000	101,145,000
Common stock, shares outstanding (in shares)	93,194,000	101,145,000

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Revenue:
Total revenue	$ 137,983	$ 100,897
Cost of revenue:
Total cost of revenue	26,788	19,389
Gross profit	111,195	81,508
Operating expenses:
Sales and marketing	90,564	80,252
Research and development	54,193	47,175
General and administrative	34,248	32,523
Total operating expenses	179,005	159,950
Loss from operations	(67,810)	(78,442)
Interest income	14,980	616
Other income (expense), net	(120)	(106)
Loss before income taxes	(52,950)	(77,932)
Provision for income taxes	308	285
Net loss	$ (53,258)	$ (78,217)
Net loss per share attributable to Class A and Class B common stockholders, basic (in dollars per share)	$ (0.28)	$ (0.43)
Net loss per share attributable to Class A and Class B common stockholders, diluted (in dollars per share)	$ (0.28)	$ (0.43)
Weighted-average shares used to compute net loss per share attributable to Class A and Class B common stockholders, basic (in shares)	190,806	182,948
Weighted-average shares used to compute net loss per share attributable to Class A and Class B common stockholders, diluted (in shares)	190,806	182,948
Subscription Revenue
Revenue:
Total revenue	$ 133,615	$ 98,384
Cost of revenue:
Total cost of revenue	22,456	16,061
Subscription Revenue | License
Revenue:
Total revenue	15,158	10,344
Cost of revenue:
Total cost of revenue	585	393
Subscription Revenue | Support
Revenue:
Total revenue	101,913	79,208
Cost of revenue:
Total cost of revenue	14,843	10,838
Subscription Revenue | Cloud-hosted services
Revenue:
Total revenue	16,544	8,832
Cost of revenue:
Total cost of revenue	7,028	4,830
Professional services and other
Revenue:
Total revenue	4,368	2,513
Cost of revenue:
Total cost of revenue	$ 4,332	$ 3,328

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Statement of Comprehensive Income [Abstract]
Net loss	$ (53,258)	$ (78,217)
Available-for-sale investments:
Unrealized loss on available-for-sale investments, net of tax	(66)	0
Comprehensive loss	$ (53,324)	$ (78,217)

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) shares in Thousands, $ in Thousands	Total	Class A and Class B Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit
Beginning balance (in shares) at Jan. 31, 2022		182,167
Beginning balance at Jan. 31, 2022	$ 1,282,291	$ 3	$ 1,788,390		$ (506,102)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		839
Issuance of common stock upon exercise of stock options	521		521
Vesting of early exercised stock options	3		3
Issuance of common stock upon settlement of restricted stock units (in shares)		710
Tax withholdings on settlement of restricted stock units (in shares)		(8)
Tax withholdings on settlement of restricted stock units	(125)		(125)
Stock-based compensation	47,141		47,141
Net loss	(78,217)				(78,217)
Ending balance (in shares) at Apr. 30, 2022		183,708
Ending balance at Apr. 30, 2022	1,251,614	$ 3	1,835,930		(584,319)
Beginning balance (in shares) at Jan. 31, 2023		189,968
Beginning balance at Jan. 31, 2023	1,205,350	$ 3	1,985,747	$ 0	(780,400)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		513
Issuance of common stock upon exercise of stock options	1,013		1,013
Issuance of common stock upon settlement of restricted stock units (in shares)		1,071
Tax withholdings on settlement of restricted stock units	(9)		(9)
Stock-based compensation	41,266		41,266
Other comprehensive loss	(66)			(66)
Net loss	(53,258)				(53,258)
Ending balance (in shares) at Apr. 30, 2023		191,552
Ending balance at Apr. 30, 2023	$ 1,194,296	$ 3	$ 2,028,017	$ (66)	$ (833,658)

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Cash flows from operating activities
Net loss	$ (53,258)	$ (78,217)
Adjustments to reconcile net loss to cash from operating activities:
Stock-based compensation expense, net of amounts capitalized	40,163	46,259
Depreciation and amortization expense	1,583	906
Non-cash operating lease cost	733	705
(Accretion) amortization of (discounts) premiums on marketable securities, net	(1,345)	0
Other	(28)	(19)
Changes in operating assets and liabilities:
Accounts receivable	59,433	36,887
Deferred contract acquisition costs	876	(6,074)
Prepaid expenses and other assets	(10,346)	(1,552)
Accounts payable	1,020	(4,702)
Accrued expenses and other liabilities	(2,243)	1,506
Accrued compensation and benefits	(5,075)	(6,328)
Deferred revenue	(25,830)	(3,361)
Customer deposits	(1,809)	271
Net cash provided by (used in) operating activities	3,874	(13,719)
Cash flows from investing activities
Purchases of property and equipment	(391)	(13)
Capitalized internal-use software	(2,739)	(1,592)
Purchases of investments	(342,330)	0
Proceeds from sales of investments	21,239	0
Net cash used in investing activities	(324,221)	(1,605)
Cash flows from financing activities
Taxes paid related to net share settlement of equity awards	(9)	(125)
Proceeds from issuance of common stock upon exercise of stock options	1,013	521
Net cash provided by financing activities	1,004	396
Net decrease in cash, cash equivalents, and restricted cash	(319,343)	(14,928)
Cash, cash equivalents, and restricted cash beginning of period	1,286,134	1,357,613
Cash, cash equivalents, and restricted cash end of period	966,791	1,342,685
Supplemental disclosure of cash flow information
Cash paid for income taxes, net of refunds received	444	215
Cash paid for operating lease liabilities	963	935
Supplemental disclosure of noncash investing and financing activities
Capitalized stock-based compensation expense	$ 1,103	$ 882

Organization and Description of

Organization and Description of Business	3 Months Ended
	Apr. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Description of Business	1. Organization and Description of Business Description of Business

Summary of Significant Accounti

Summary of Significant Accounting Policies	3 Months Ended
	Apr. 30, 2023
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	2. Summary of Significant Accounting Policies Basis of Presentation The accompanying condensed consolidated financial statements have been prepared in conformity with generally accepted accounting principles in the United States of America ("U.S. GAAP" or "GAAP") and include the accounts of the Company and its wholly owned subsidiaries. Certain information and note disclosures normally included in the financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to the applicable rules and regulations of the Securities and Exchange Commission (the "SEC"). The condensed balance sheet data as of January 31, 2023 was derived from the Company’s audited financial statements included in its Annual Report on Form 10-K for the fiscal year ended January 31, 2023 (the “2023 Form 10-K”), but does not include all disclosures required by U.S. GAAP. Therefore, these interim condensed consolidated financial statements and accom panying footnotes should be read in conjunction with the Company’s annual consolidated financial statements and related footnotes included in its Annual Report on Form 10-K for the fiscal year ended January 31, 2023 (the “fiscal 2023 Form 10-K”). The accompanying condensed consolidated financial statements reflect all adjustments, consisting only of normal recurring adjustments, that are, in the opinion of management, necessary for the fair presentation of the Company’s financial position, results of operations, cash flows, and stockholders’ equity for the interim periods presented. The results of operations for the three months ended April 30, 2023 shown in this report are not necessarily indicative of the results to be expected for the full year ending January 31, 2024 or any other period. Principles of Consolidation The condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. Use of Estimates The preparation of condensed consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of income and expense during the reporting period. Such management estimates include, but are not limited to, the determination of standalone selling prices of the Company’s performance obligations, the estimated period of benefit of deferred contract acquisition costs, the fair value of share-based awards, fair value of investments, software development costs, discount rates used for operating leases, amortization and accretion of interest on investments, and accounting for income taxes, including the valuation allowance on deferred tax assets and uncertain tax positions. These estimates are based on information available as of the date of the condensed consolidated financial statements; therefore, actual results could differ from those estimates. Accumulated Other Comprehensive Loss As of April 30, 2023, accumulated other comprehensive loss was comprised of unrealized losses from our available-for-sale investments. Significant Accounting Policies Other than the short-term investment policy described below, there have been no changes to the Company’s significant accounting policies described in the fiscal 2023 Form 10-K that have had a material impact on these condensed consolidated financial statements and related notes. Short-Term Investments The Company’s investments consist of U.S. treasury securities, corporate notes and bonds, U.S. agency obligations, commercial paper, and certificates of deposit. The Company determines the appropriate classification of its investments at the time of purchase and reevaluates such determination at each balance sheet date. The Company has classified and accounted for its investments as available-for-sale securities. The Company may sell these securities at any time for use in its current operations or for other purposes, even prior to maturity. As a result, the Company classifies its investments, including those with maturities beyond twelve months, as current assets in the consolidated balance sheets. Available-for-sale securities are recorded at fair value each reporting period, and are adjusted for amortization of premiums and accretion of discounts to maturity and such amortization and accretion are included in interest income in the condensed consolidated statements of operations. Realized gains and losses are determined based on the specific identification method and are reported in other income (expense), net in the condensed consolidated statements of operations. Unrealized gains are reported as a separate component of accumulated other comprehensive loss on the condensed consolidated balance sheets until realized. For available-for-sale securities in an unrealized loss position, the Company first assesses whether it intends to sell the security or it is more likely than not that the Company will be required to sell the security before the recovery of its entire amortized cost basis. If either of these criteria is met, the security’s amortized cost basis is written down to fair value through other income (expense), net in the condensed consolidated statements of operations. If neither of these criteria is met, the Company evaluates whether the decline in fair value below amortized cost is due to credit or non-credit related factors. In making this assessment, the Company considers the extent to which fair value is less than amortized cost, any changes to the rating of the security by a rating agency, and any adverse conditions specifically related to the security, among other factors. Credit related unrealized losses are recognized as an allowance for expected credit losses of available-for-sale debt securities on the condensed consolidated balance sheets with a corresponding charge in other income (expense), net in the condensed consolidated statements of operations. Non-credit related unrealized losses are included in accumulated other comprehensive loss.

Revenue and Performance Obligat

Revenue and Performance Obligations	3 Months Ended
	Apr. 30, 2023
Disaggregation of Revenue [Abstract]
Revenue and Performance Obligations	3. Revenue and Performance Obligations Disaggregation of revenue The following table presents revenue by category (dollars in thousands): Three Months Ended April 30, 2023 2022 Amount % of Total Amount % of Total License $ 15,158 11 % $ 10,344 10 % Support 101,913 74 79,208 79 Cloud-hosted services 16,544 12 8,832 9 Total subscription revenue 133,615 97 98,384 98 Professional services and other 4,368 3 2,513 2 Total revenue $ 137,983 100 % $ 100,897 100 % The following table summarizes the revenue by region based on the billing address of customers who have contracted to use the Company's products and services (dollars in thousands): Three Months Ended April 30, 2023 2022 Amount % of Total Amount % of Total United States $ 98,557 71 % $ 72,791 72 % Rest of the world 39,426 29 % 28,106 28 % Total $ 137,983 100 % $ 100,897 100 % No other country, outside of the United States, exceeded 10% of total revenue during the periods presented. Contract Balances Changes in deferred revenue and unbilled accounts receivable were as follows (in thousands): Three Months Ended April 30, 2023 2022 Balance, beginning of period $ 302,244 $ 223,289 Deferred revenue billings including reclassification to deferred revenue from customer deposits 113,046 98,094 Recognition of revenue, net of change in unbilled accounts receivable* (138,876) (101,455) Balance, end of period $ 276,414 $ 219,928 * Reconciliation to revenue reported per consolidated statements of operations: Revenue billed as of the end of the period $ 138,876 $ 101,455 Increase (decrease) in total unbilled accounts receivable (893) (558) Revenue reported per consolidated statements of operations $ 137,983 $ 100,897 Unbilled accounts receivable represents revenue recognized on contracts for which billings have not yet been presented to customers because the amounts were earned but not contractually billable as of the balance sheet date. The unbilled accounts receivable balance is due within one year. As of April 30, 2023 and January 31, 2023, unbilled accounts receivable of approximately $4.0 million and $4.9 million, respectively, were included in accounts receivable on the Company’s condensed consolidated balance sheets. Remaining Performance Obligations (RPOs) The typical stated customer contract term is one year but can range up to three years. RPOs include both deferred revenue and non-cancelable contracted amounts that will be invoiced and recognized as revenue in future periods. As of April 30, 2023 and January 31, 2023, the Company had $635.3 million and $647.1 million, respectively, of remaining performance obligations, which is comprised of product and services revenue not yet delivered. As of April 30, 2023 and January 31, 2023, the Company expected to recognize approximately 59% and 58%, respectively, of its remaining performance obligations as revenue over the next 12 months and the remainder thereafter. RPOs exclude customer deposits, which are refundable pre-paid amounts that are expected to be recognized as revenue in future periods. These balances are included in customer deposits in the condensed consolidated balance sheets and are classified as current because contractually customers can cancel these obligations with 30 days written notice. The customer deposit balance is amortized to revenue over the term of the underlying contract as the customer’s right to cancel expires. If no contracts with customers are cancelled, the existing customer deposit balance will be recognized to revenue over the remaining stated term of the underlying contract which may be over the next 12 months or longer as follows (in thousands): As of April 30, 2023 January 31, 2023 Within the next 12 months $ 21,144 $ 22,657 After the next 12 months 3,746 4,042 Total $ 24,890 $ 26,699

Short-Term Investments

Short-Term Investments	3 Months Ended
	Apr. 30, 2023
Investments, Debt and Equity Securities [Abstract]
Short-Term Investments	4. Short-Term Investments The following tables summarize the fair values of the Company’s short-term investments (in thousands): Three Months Ended April 30, 2023 Amortized Cost Unrealized Gains Unrealized Losses Fair Value U.S. treasury securities $ 182,660 $ 44 $ (226) $ 182,478 U.S. agency obligations 46,327 134 (10) 46,451 Corporate notes and bonds 51,464 43 (49) 51,458 Commercial paper 28,992 — — 28,992 Certificates of deposit 13,016 — — 13,016 Total short-term investments $ 322,459 $ 221 $ (285) $ 322,395 As of April 30, 2023, available-for-sale short-term investments had a fair value of $322.4 million. The Company does not intend to sell these investments and it is more likely than not that the Company will hold these short-term investments until maturity or a recovery of the cost basis. The Company determined that the decline in fair value of short-term investments was not due to credit-related factors, and no allowance for expected credit losses was recorded as of April 30, 2023. Realized gains and losses were not material for the three months ended April 30, 2023. The following table summarizes the contractual maturities of the Company’s short-term investments (in thousands): April 30, 2023 Amortized Cost Fair Value Due within one year $ 270,424 $ 270,353 Due after one year through three years 52,035 52,042 Total $ 322,459 $ 322,395

Fair Value Measurements

Fair Value Measurements	3 Months Ended
	Apr. 30, 2023
Fair Value Disclosures [Abstract]
Fair Value Measurements	5. Fair Value Measurements The following table sets forth the financial assets, measured at fair value, by level within the fair value hierarchy on a recurring basis and indicates the fair value hierarchy of the valuation inputs used to determine such fair value (in thousands): Fair Value Measurement As of April 30, 2023 Fair Value Level Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value Assets: Cash and Cash equivalents: Cash $ 863,524 $ — $ — $ 863,524 Money market funds Level 1 82,083 — — 82,083 U.S. treasury securities Level 2 10,485 — (2) 10,483 Corporate notes and bonds Level 2 1,126 — — 1,126 Commercial paper Level 2 8,075 — — 8,075 Certificates of deposit Level 2 1,500 — — 1,500 Total cash and cash equivalents $ 966,793 $ — $ (2) $ 966,791 Short-term investments: U.S. treasury securities Level 2 $ 182,660 $ 44 $ (226) $ 182,478 U.S. agency obligations Level 2 46,327 134 (10) 46,451 Corporate notes and bonds Level 2 51,464 43 (49) 51,458 Commercial paper Level 2 28,992 — — 28,992 Certificates of deposit Level 2 13,016 — — 13,016 Total short-term investments $ 322,459 $ 221 $ (285) $ 322,395 Total assets measured at fair value $ 1,289,252 $ 221 $ (287) $ 1,289,186 The following table summarizes the respective fair value and the classification by level within the fair value hierarchy (in thousands): Fair Value Measurement As of January 31, 2023 Level 1 Level 2 Level 3 Total Cash and cash equivalents Money market funds $ 169,904 $ — $ — $ 169,904 Total cash and cash equivalents 169,904 — — 169,904 Total assets measured at fair value $ 169,904 $ — $ — $ 169,904 The Company classifies its highly liquid money market funds within Level 1 of the fair value hierarchy because they are valued based on quoted market prices in active markets. The Company classifies its corporate notes and bonds, U.S. treasury securities, U.S. agency obligations, commercial paper, and CDs within Level 2 of the fair value hierarchy because they are valued using inputs other than quoted prices that are directly or indirectly observable in the market, including readily available pricing sources for the identical underlying security that may not be actively traded. As of April 30, 2023, the declines in the market value of the Company's investment portfolio were not driven by credit related factors. During the three months ended April 30, 2023, the Company determined that it does not intend to sell any securities with a decline in market value, and it is more likely than not that the Company will be able to hold these securities until the entire principal has been recovered. Therefore, the Company did not recognize any losses on the investments due to credit related factors. As of April 30, 2023, the total unrealized losses were not material. The condensed consolidated financial statements as of April 30, 2023 and January 31, 2023 do not include any nonrecurring fair value measurements relating to assets or liabilities. There were no transfers between fair value measurement levels during the three months ended April 30, 2023.

Balance Sheet Components

Balance Sheet Components	3 Months Ended
	Apr. 30, 2023
Supplemental Balance Sheet Disclosures [Abstract]
Balance Sheet Components	6. Balance Sheet Components Other Assets, Non-Current Other assets, non-current are comprised of the following (in thousands): As of April 30, 2023 January 31, 2023 Property and equipment, net $ 27,244 $ 24,594 Operating lease right-of-use assets 11,827 12,560 Other 2,171 902 Total other assets, non-current $ 41,242 $ 38,056 Property and Equipment, Net Property and equipment, net are included in other assets, non-current in the condensed consolidated balance sheets and are comprised of the following (in thousands): Estimated As of April 30, 2023 January 31, 2023 Furniture and fixtures 5 years $ 1,330 $ 1,292 Computers, equipment and software 3 years 581 581 Capitalized internal-use software development costs 5 years 29,635 25,817 Leasehold improvements Shorter of useful life or lease term 5,484 5,138 Construction in progress 77 47 Total property and equipment 37,107 32,875 Less: accumulated depreciation and amortization (9,863) (8,281) Property and equipment, net $ 27,244 $ 24,594 Total depreciation and amortization expense for three months ended April 30, 2023 and 2022 was $1.6 million and $0.9 million, respectively. The Company capitalized $3.8 million and $2.5 million in internal-use software development costs for the three months ended April 30, 2023 and 2022, respectively. Amortization expense associated with internal-use software development costs totaled $1.3 million and $0.6 million for three months ended April 30, 2023 and 2022, respectively. Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities are comprised of the following (in thousands): As of April 30, 2023 January 31, 2023 Accrued expenses $ 3,013 $ 4,222 Operating lease liabilities 3,488 3,380 Accrued income taxes payable 991 1,081 Sales tax payable 1,343 1,480 Total accrued expenses and other current liabilities $ 8,835 $ 10,163 Accrued Compensation and Benefits Accrued compensation and benefits are comprised of the following (in thousands): As of April 30, 2023 January 31, 2023 Accrued commissions $ 9,876 $ 16,932 Accrued vacation 22,557 20,614 Accrued payroll and withholding taxes 8,361 11,574 ESPP employee contributions 9,432 4,247 Accrued bonus 2,729 3,220 Other 519 2,041 Total accrued compensation and benefits $ 53,474 $ 58,628 Deferred Contract Acquisition Costs The following table summarizes the activity of deferred contract acquisition costs (in thousands): Three Months Ended April 30, 2023 2022 Beginning balance $ 124,098 $ 89,331 Capitalization of contract acquisition costs 11,663 15,212 Amortization of deferred contract acquisition costs (12,539) (9,138) Ending balance 123,222 95,405 Deferred contract acquisition costs, current $ 42,995 $ 32,200 Deferred contract acquisition costs, non-current 80,227 63,205 Total deferred contract acquisition costs $ 123,222 $ 95,405 There were no impairment losses recognized for deferred contract acquisition costs during the three months ended April 30, 2023 and 2022. Other Liabilities, Non-Current The following table summarizes the activity of other liabilities, non-current (in thousands): As of April 30, 2023 January 31, 2023 Operating lease liabilities, non-current $ 11,178 $ 12,093 Accrued commissions, non-current 792 713 Total other liabilities, non-current $ 11,970 $ 12,806

Leases

Leases	3 Months Ended
	Apr. 30, 2023
Leases [Abstract]
Leases	7. Leases The Company leases office spaces under noncancelable operating lease agreements, which expire at various dates through 2027. The Company is required to pay property taxes, insurance, and normal maintenance costs for certain of these facilities. Operating lease cost for these leases is recognized on a straight-line basis over the lease term, with variable lease costs recognized in the period incurred. These lease agreements do not contain residual value guarantees or restrictive covenants. Lease costs Lease costs were as follows (in thousands): Three Months Ended April 30, 2023 2022 Short-term lease costs $ 156 $ 100 Operating lease costs 878 878 Total lease costs $ 1,034 $ 978 Variable lease cost was not significant for the three months ended April 30, 2023 and 2022. There were no other lease components for the periods presented. Lease term and discount rate information are summarized as follows: As of April 30, 2023 Weighted average remaining lease terms (in years) 3.9 Weighted average discount rate 3.8 % Future lease payments under noncancelable operating leases on an undiscounted cash flow basis as of April 30, 2023 are as follows (in thousands): Years Ending January 31, Amount 2024 (remaining nine months) $ 2,961 2025 4,150 2026 3,734 2027 3,737 2028 1,277 Total minimum lease payments 15,859 Less imputed interest (1,193) Present value of future minimum lease payments 14,666 Less current lease liabilities (3,488) Operating lease liabilities, non-current $ 11,178 Operating lease liabilities are included in accrued expenses and other current liabilities, and non-current lease liabilities are included in other liabilities, non-current, in the condensed consolidated balance sheets. There were no lease related operating right-of-use asset impairment losses in the three months ended April 30, 2023 and 2022.

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Apr. 30, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	8. Commitments and Contingencies Letter of credit The Company has a total of $1.8 million in letters of credit outstanding as security deposits for the Company’s leased office spaces as of April 30, 2023 and January 31, 2023. Litigation From time to time, the Company may become involved in various legal proceedings in the ordinary course of its business and may be subject to third-party infringement claims. In the normal course of business, the Company may agree to indemnify third parties with whom it enters into contractual relationships, including customers, lessors, and parties to other transactions with the Company, with respect to certain matters. The Company has agreed, under certain conditions, to hold these third parties harmless against specified losses, such as those arising from a breach of representations or covenants, other third-party claims that the Company’s products when used for their intended purposes infringe the intellectual property rights of such other third parties, or other claims made against certain parties. It is not possible to determine the maximum potential amount of liability under these indemnification obligations due to the Company’s limited history of prior indemnification claims and the unique facts and circumstances that are likely to be involved in each particular claim.

Common Stock and Stockholders'

Common Stock and Stockholders' Equity	3 Months Ended
	Apr. 30, 2023
Equity [Abstract]
Common Stock and Stockholders' Equity	9. Common Stock and Stockholders' Equity Common Stock Reserved for Future Issuance The Company reserved shares of common stock for future issuance as follows (in thousands): As of April 30, 2023 January 31, 2023 Options outstanding 8,801 9,315 Restricted stock units outstanding 12,064 11,588 Remaining shares available for future issuance under the 2021 Equity Incentive Plan ("2021 Plans") 29,419 21,466 2021 Employee Stock Purchase Plan ("ESPP") 4,907 3,008 Total 55,191 45,377 Stock Options The following table summarizes stock option activity for the 2021 Plan (shares and aggregate intrinsic value in thousands): Options Outstanding Number of Options Outstanding Weighted- Average Exercise Price Weighted- Average Remaining Contractual Aggregate Intrinsic Value Balance as of January 31, 2023 9,315 $ 1.92 4.6 $ 281,837 Stock options exercised (513) 1.98 14,679 Stock options cancelled/forfeited/expired (1) 5.70 Balance as of April 30, 2023 8,801 1.92 4.5 219,062 Exercisable as of April 30, 2023 8,678 $ 1.77 4.4 $ 217,340 The total grant-date fair value of stock options vested was $0.5 million and $1.3 million during the three months ended April 30, 2023 and 2022. The total intrinsic value of options exercised during the three months ended April 30, 2023 and 2022 were $14.7 million and $34.8 million, respectively. Restricted Stock Units The Company’s summary of restricted stock units ("RSUs") activity under the 2021 Plan is as follows (in thousands): Number of Awards Weighted-Average Grant Date Fair Value Outstanding and unvested at January 31, 2023 11,588 $ 42.48 RSUs granted 1,939 $ 31.89 RSUs released (1,071) $ 35.74 RSUs cancelled (392) $ 42.61 Outstanding and unvested at April 30, 2023 12,064 $ 41.37 The total grant-date fair value of RSUs vested was $38.3 million and $17.5 million during the three months ended April 30, 2023 and 2022. Employee Stock Purchase Plan A total of 4,907,132 shares of Class A common stock are available for future issuance under the ESPP as of April 30, 2023. For the three months ended April 30, 2023 and 2022, the Company recognized $3.0 million and $3.1 million of stock-based compensation expense related to the ESPP, respectively. As of April 30, 2023, unrecognized stock-based compensation expense related to the ESPP was approximately $19.0 million, which is expected to be recognized over a weighted-average period of approximately 1.6 years. The Company’s current offering period began December 15, 2022 and is expected to end December 15, 2024. ESPP employee payroll contributions accrued as of April 30, 2023 were $9.4 million and are reported within accrued compensation and benefits in the consolidated balance sheets. Payroll contributions accrued as of April 30, 2023 will be used to purchase shares at the end of the current purchase period ending on June 15, 2023. Payroll contributions ultimately used to purchase shares will be reclassified as stockholders’ equity on the purchase date. Stock-Based Compensation Expense Total stock-based compensation expense recognized in the Company’s condensed consolidated statements of operations is as follows (in thousands): Three Months Ended April 30, 2023 2022 Cost of support $ 2,256 $ 1,959 Cost of cloud-hosted services 609 640 Cost of professional services and other 566 728 Sales and marketing 11,959 14,393 Research and development 11,731 14,738 General and administrative 13,042 13,801 Stock-based compensation expense, net of amounts capitalized $ 40,163 $ 46,259 Capitalized stock-based compensation 1,103 882 Total stock-based compensation expense $ 41,266 $ 47,141 As of April 30, 2023 and 2022, total unrecognized stock-based compensation expense related to RSUs was approximately $359.5 million and $420.6 million, respectively. This unrecognized stock-based compensation expense is expected to be recognized over a weighted-average period of approximately 2.9 years and 3.1 years, respectively. As of April 30, 2023, and 2022, total unrecognized stock-based compensation expense related to unvested stock options was approximately $0.9 million and $4.0 million, respectively, which are expected to be recognized over a weighted-average period of approximately 1.2 years and 1.5 years, respectively.

Net Loss Per Share Attributable

Net Loss Per Share Attributable to Common Stockholders	3 Months Ended
	Apr. 30, 2023
Earnings Per Share [Abstract]
Net Loss Per Share Attributable to Common Stockholders	10. Net Loss Per Share Attributable to Common Stockholders For periods in which there were Class A and Class B shares outstanding, the rights, including the liquidation and dividend rights, of the holders of Class A and Class B common stock were identical, except with respect to voting, converting, and transfer rights. Our Class B common stock has ten votes per share, and our Class A common stock has one vote per share. As the liquidation and dividend rights were identical for Class A and Class B common stock, the undistributed earnings would be allocated on a proportionate basis and the resulting net loss per share would, therefore, be the same for both Class A and Class B common stock on an individual or combined basis. The following table sets forth the computation of basic and diluted net loss per share attributable to common stockholders (in thousands, except per share data): Three Months Ended April 30, 2023 2022 Numerator: Net loss $ (53,258) $ (78,217) Denominator: Weighted-average shares used to compute net loss per share attributable to Class A and Class B common stockholders, basic and diluted 190,806 182,948 Net loss per share attributable to Class A and Class B common stockholders, basic and diluted $ (0.28) $ (0.43) The following outstanding potentially dilutive shares of common stock were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented because the impact of including them would have been antidilutive (in thousands): Three Months Ended April 30, 2023 2022 Outstanding stock options and restricted stock units 20,868 24,646 Share purchase rights under the ESPP 1,999 947 Class A and Class B common stock subject to repurchase — 3 Total 22,867 25,596

Income Taxes

Income Taxes	3 Months Ended
	Apr. 30, 2023
Income Tax Disclosure [Abstract]
Income Taxes	11. Income Taxes The Company determines its income tax provision for interim periods using an estimate of its annual effective tax rate adjusted for discrete items occurring during the periods presented. The primary difference between its effective tax rate and the federal statutory rate is the full valuation allowance it has established on the federal and state net operating losses and credits. The provision for income taxes recorded in the three months ended April 30, 2023 and 2022 consists primarily of income taxes in foreign jurisdictions in which the Company conducts business. The Company is subject to income tax in the United States, certain states, and various foreign countries. Due to the history of net operating losses, the Company is subject to United States federal, state, and local examinations by tax authorities for all years since incorporation.

Subsequent Events

Subsequent Events	3 Months Ended
	Apr. 30, 2023
Subsequent Events [Abstract]
Subsequent Events	12. Subsequent Events The Company evaluated subsequent events through June 7, 2023, which is the date the audited consolidated financial statements were available to be issued. On June 7, 2023 we initiated a workforce reduction plan impacting approximately 8% of the Company’s workforce. The workforce reduction plan is intended to increase operational efficiency, decrease costs and increase profitability. The Company expects to substantially complete the reduction plan during the second quarter of fiscal 2024. The Company expects to recognize charges in connection with the workforce reduction plan for severance payments and benefits continuation estimated at between $7.5 million and $9.0 million, excluding the impact of stock-based compensation expense, which is expected to be immaterial. The Company expects these expenses to be recognized and paid primarily in the second quarter of fiscal 2024. The Company expects the workforce reduction plan will reduce annual recurring cash employee expenses by approximately $36.0 million.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Apr. 30, 2023
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying condensed consolidated financial statements have been prepared in conformity with generally accepted accounting principles in the United States of America ("U.S. GAAP" or "GAAP") and include the accounts of the Company and its wholly owned subsidiaries. Certain information and note disclosures normally included in the financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to the applicable rules and regulations of the Securities and Exchange Commission (the "SEC"). The condensed balance sheet data as of January 31, 2023 was derived from the Company’s audited financial statements included in its Annual Report on Form 10-K for the fiscal year ended January 31, 2023 (the “2023 Form 10-K”), but does not include all disclosures required by U.S. GAAP. Therefore, these interim condensed consolidated financial statements and accom panying footnotes should be read in conjunction with the Company’s annual consolidated financial statements and related footnotes included in its Annual Report on Form 10-K for the fiscal year ended January 31, 2023 (the “fiscal 2023 Form 10-K”). The accompanying condensed consolidated financial statements reflect all adjustments, consisting only of normal recurring adjustments, that are, in the opinion of management, necessary for the fair presentation of the Company’s financial position, results of operations, cash flows, and stockholders’ equity for the interim periods presented. The results of operations for the three months ended April 30, 2023 shown in this report are not necessarily indicative of the results to be expected for the full year ending January 31, 2024 or any other period.
Principles of Consolidation	Principles of Consolidation The condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.
Use of Estimates	Use of Estimates The preparation of condensed consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of income and expense during the reporting period. Such management estimates include, but are not limited to, the determination of standalone selling prices of the Company’s performance obligations, the estimated period of benefit of deferred contract acquisition costs, the fair value of share-based awards, fair value of investments, software development costs, discount rates used for operating leases, amortization and accretion of interest on investments, and accounting for income taxes, including the valuation allowance on deferred tax assets and uncertain tax positions. These estimates are based on
Accumulated Other Comprehensive Loss	Accumulated Other Comprehensive Loss As of April 30, 2023, accumulated other comprehensive loss was comprised of unrealized losses from our available-for-sale investments.
Significant Accounting Policies	Significant Accounting Policies Other than the short-term investment policy described below, there have been no changes to the Company’s significant accounting policies described in the fiscal 2023 Form 10-K that have had a material impact on these condensed consolidated financial statements and related notes.
Short-Term Investments	Short-Term Investments The Company’s investments consist of U.S. treasury securities, corporate notes and bonds, U.S. agency obligations, commercial paper, and certificates of deposit. The Company determines the appropriate classification of its investments at the time of purchase and reevaluates such determination at each balance sheet date. The Company has classified and accounted for its investments as available-for-sale securities. The Company may sell these securities at any time for use in its current operations or for other purposes, even prior to maturity. As a result, the Company classifies its investments, including those with maturities beyond twelve months, as current assets in the consolidated balance sheets. Available-for-sale securities are recorded at fair value each reporting period, and are adjusted for amortization of premiums and accretion of discounts to maturity and such amortization and accretion are included in interest income in the condensed consolidated statements of operations. Realized gains and losses are determined based on the specific identification method and are reported in other income (expense), net in the condensed consolidated statements of operations. Unrealized gains are reported as a separate component of accumulated other comprehensive loss on the condensed consolidated balance sheets until realized. For available-for-sale securities in an unrealized loss position, the Company first assesses whether it intends to sell the security or it is more likely than not that the Company will be required to sell the security before the recovery of its entire amortized cost basis. If either of these criteria is met, the security’s amortized cost basis is written down to fair value through other income (expense), net in the condensed consolidated statements of operations. If neither of these criteria is met, the Company evaluates whether the decline in fair value below amortized cost is due to credit or non-credit related factors. In making this assessment, the Company considers the extent to which fair value is less than amortized cost, any changes to the rating of the security by a rating agency, and any adverse conditions specifically related to the security, among other factors. Credit related unrealized losses are recognized as an allowance for expected credit losses of available-for-sale debt securities on the condensed consolidated balance sheets with a corresponding charge in other income (expense), net in the condensed consolidated statements of operations. Non-credit related unrealized losses are included in accumulated other comprehensive loss.

Revenue and Performance Oblig_2

Revenue and Performance Obligations (Tables)	3 Months Ended
	Apr. 30, 2023
Disaggregation of Revenue [Abstract]
Summary of Revenue Disaggregated by Category	The following table presents revenue by category (dollars in thousands): Three Months Ended April 30, 2023 2022 Amount % of Total Amount % of Total License $ 15,158 11 % $ 10,344 10 % Support 101,913 74 79,208 79 Cloud-hosted services 16,544 12 8,832 9 Total subscription revenue 133,615 97 98,384 98 Professional services and other 4,368 3 2,513 2 Total revenue $ 137,983 100 % $ 100,897 100 %
Summary of Revenue By Region Based On The Billing Address of Customers	The following table summarizes the revenue by region based on the billing address of customers who have contracted to use the Company's products and services (dollars in thousands): Three Months Ended April 30, 2023 2022 Amount % of Total Amount % of Total United States $ 98,557 71 % $ 72,791 72 % Rest of the world 39,426 29 % 28,106 28 % Total $ 137,983 100 % $ 100,897 100 %
Summary of Changes in Deferred Revenue and Unbilled Accounts Receivable	Changes in deferred revenue and unbilled accounts receivable were as follows (in thousands): Three Months Ended April 30, 2023 2022 Balance, beginning of period $ 302,244 $ 223,289 Deferred revenue billings including reclassification to deferred revenue from customer deposits 113,046 98,094 Recognition of revenue, net of change in unbilled accounts receivable* (138,876) (101,455) Balance, end of period $ 276,414 $ 219,928 * Reconciliation to revenue reported per consolidated statements of operations: Revenue billed as of the end of the period $ 138,876 $ 101,455 Increase (decrease) in total unbilled accounts receivable (893) (558) Revenue reported per consolidated statements of operations $ 137,983 $ 100,897
Summary of Revenue Recognized Related to Customer Deposit Balance	If no contracts with customers are cancelled, the existing customer deposit balance will be recognized to revenue over the remaining stated term of the underlying contract which may be over the next 12 months or longer as follows (in thousands): As of April 30, 2023 January 31, 2023 Within the next 12 months $ 21,144 $ 22,657 After the next 12 months 3,746 4,042 Total $ 24,890 $ 26,699

Short-Term Investments (Tables)

Short-Term Investments (Tables)	3 Months Ended
	Apr. 30, 2023
Investments, Debt and Equity Securities [Abstract]
Summary of fair value of short-term investments	The following tables summarize the fair values of the Company’s short-term investments (in thousands): Three Months Ended April 30, 2023 Amortized Cost Unrealized Gains Unrealized Losses Fair Value U.S. treasury securities $ 182,660 $ 44 $ (226) $ 182,478 U.S. agency obligations 46,327 134 (10) 46,451 Corporate notes and bonds 51,464 43 (49) 51,458 Commercial paper 28,992 — — 28,992 Certificates of deposit 13,016 — — 13,016 Total short-term investments $ 322,459 $ 221 $ (285) $ 322,395
Summary of contractual maturities	The following table summarizes the contractual maturities of the Company’s short-term investments (in thousands): April 30, 2023 Amortized Cost Fair Value Due within one year $ 270,424 $ 270,353 Due after one year through three years 52,035 52,042 Total $ 322,459 $ 322,395

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	3 Months Ended
	Apr. 30, 2023
Fair Value Disclosures [Abstract]
Schedule of Financial Assets Measured at Fair Value on a Recurring Basis	The following table sets forth the financial assets, measured at fair value, by level within the fair value hierarchy on a recurring basis and indicates the fair value hierarchy of the valuation inputs used to determine such fair value (in thousands): Fair Value Measurement As of April 30, 2023 Fair Value Level Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value Assets: Cash and Cash equivalents: Cash $ 863,524 $ — $ — $ 863,524 Money market funds Level 1 82,083 — — 82,083 U.S. treasury securities Level 2 10,485 — (2) 10,483 Corporate notes and bonds Level 2 1,126 — — 1,126 Commercial paper Level 2 8,075 — — 8,075 Certificates of deposit Level 2 1,500 — — 1,500 Total cash and cash equivalents $ 966,793 $ — $ (2) $ 966,791 Short-term investments: U.S. treasury securities Level 2 $ 182,660 $ 44 $ (226) $ 182,478 U.S. agency obligations Level 2 46,327 134 (10) 46,451 Corporate notes and bonds Level 2 51,464 43 (49) 51,458 Commercial paper Level 2 28,992 — — 28,992 Certificates of deposit Level 2 13,016 — — 13,016 Total short-term investments $ 322,459 $ 221 $ (285) $ 322,395 Total assets measured at fair value $ 1,289,252 $ 221 $ (287) $ 1,289,186 The following table summarizes the respective fair value and the classification by level within the fair value hierarchy (in thousands): Fair Value Measurement As of January 31, 2023 Level 1 Level 2 Level 3 Total Cash and cash equivalents Money market funds $ 169,904 $ — $ — $ 169,904 Total cash and cash equivalents 169,904 — — 169,904 Total assets measured at fair value $ 169,904 $ — $ — $ 169,904

Balance Sheet Components (Table

Balance Sheet Components (Tables)	3 Months Ended
	Apr. 30, 2023
Supplemental Balance Sheet Disclosures [Abstract]
Summary of Other Assets Non-current	Other assets, non-current are comprised of the following (in thousands): As of April 30, 2023 January 31, 2023 Property and equipment, net $ 27,244 $ 24,594 Operating lease right-of-use assets 11,827 12,560 Other 2,171 902 Total other assets, non-current $ 41,242 $ 38,056
Summary of Property and Equipment, Net	Property and equipment, net are included in other assets, non-current in the condensed consolidated balance sheets and are comprised of the following (in thousands): Estimated As of April 30, 2023 January 31, 2023 Furniture and fixtures 5 years $ 1,330 $ 1,292 Computers, equipment and software 3 years 581 581 Capitalized internal-use software development costs 5 years 29,635 25,817 Leasehold improvements Shorter of useful life or lease term 5,484 5,138 Construction in progress 77 47 Total property and equipment 37,107 32,875 Less: accumulated depreciation and amortization (9,863) (8,281) Property and equipment, net $ 27,244 $ 24,594
Summary of Accrued Expenses and Other Current Liabilities	Accrued expenses and other current liabilities are comprised of the following (in thousands): As of April 30, 2023 January 31, 2023 Accrued expenses $ 3,013 $ 4,222 Operating lease liabilities 3,488 3,380 Accrued income taxes payable 991 1,081 Sales tax payable 1,343 1,480 Total accrued expenses and other current liabilities $ 8,835 $ 10,163
Summary of Accrued Compensation and Benefits	Accrued compensation and benefits are comprised of the following (in thousands): As of April 30, 2023 January 31, 2023 Accrued commissions $ 9,876 $ 16,932 Accrued vacation 22,557 20,614 Accrued payroll and withholding taxes 8,361 11,574 ESPP employee contributions 9,432 4,247 Accrued bonus 2,729 3,220 Other 519 2,041 Total accrued compensation and benefits $ 53,474 $ 58,628
Summary of Activity of Deferred Contract Acquisition Costs	The following table summarizes the activity of deferred contract acquisition costs (in thousands): Three Months Ended April 30, 2023 2022 Beginning balance $ 124,098 $ 89,331 Capitalization of contract acquisition costs 11,663 15,212 Amortization of deferred contract acquisition costs (12,539) (9,138) Ending balance 123,222 95,405 Deferred contract acquisition costs, current $ 42,995 $ 32,200 Deferred contract acquisition costs, non-current 80,227 63,205 Total deferred contract acquisition costs $ 123,222 $ 95,405
Schedule of Other Liabilities, Non-current	The following table summarizes the activity of other liabilities, non-current (in thousands): As of April 30, 2023 January 31, 2023 Operating lease liabilities, non-current $ 11,178 $ 12,093 Accrued commissions, non-current 792 713 Total other liabilities, non-current $ 11,970 $ 12,806

Leases (Tables)

Leases (Tables)	3 Months Ended
	Apr. 30, 2023
Leases [Abstract]
Schedule of Lease Costs	Lease costs were as follows (in thousands): Three Months Ended April 30, 2023 2022 Short-term lease costs $ 156 $ 100 Operating lease costs 878 878 Total lease costs $ 1,034 $ 978
Summary of Lease Term and Discount Rate	Lease term and discount rate information are summarized as follows: As of April 30, 2023 Weighted average remaining lease terms (in years) 3.9 Weighted average discount rate 3.8 %
Schedule of Future Lease Payments	Future lease payments under noncancelable operating leases on an undiscounted cash flow basis as of April 30, 2023 are as follows (in thousands): Years Ending January 31, Amount 2024 (remaining nine months) $ 2,961 2025 4,150 2026 3,734 2027 3,737 2028 1,277 Total minimum lease payments 15,859 Less imputed interest (1,193) Present value of future minimum lease payments 14,666 Less current lease liabilities (3,488) Operating lease liabilities, non-current $ 11,178

Common Stock and Stockholders_2

Common Stock and Stockholders' Equity (Tables)	3 Months Ended
	Apr. 30, 2023
Equity [Abstract]
Schedule of Reserved Shares of Common Stock for Future Issuance	The Company reserved shares of common stock for future issuance as follows (in thousands): As of April 30, 2023 January 31, 2023 Options outstanding 8,801 9,315 Restricted stock units outstanding 12,064 11,588 Remaining shares available for future issuance under the 2021 Equity Incentive Plan ("2021 Plans") 29,419 21,466 2021 Employee Stock Purchase Plan ("ESPP") 4,907 3,008 Total 55,191 45,377
Schedule of Stock Option Activity	The following table summarizes stock option activity for the 2021 Plan (shares and aggregate intrinsic value in thousands): Options Outstanding Number of Options Outstanding Weighted- Average Exercise Price Weighted- Average Remaining Contractual Aggregate Intrinsic Value Balance as of January 31, 2023 9,315 $ 1.92 4.6 $ 281,837 Stock options exercised (513) 1.98 14,679 Stock options cancelled/forfeited/expired (1) 5.70 Balance as of April 30, 2023 8,801 1.92 4.5 219,062 Exercisable as of April 30, 2023 8,678 $ 1.77 4.4 $ 217,340
Schedule of Restricted Stock Units (RSUs") Activity	The Company’s summary of restricted stock units ("RSUs") activity under the 2021 Plan is as follows (in thousands): Number of Awards Weighted-Average Grant Date Fair Value Outstanding and unvested at January 31, 2023 11,588 $ 42.48 RSUs granted 1,939 $ 31.89 RSUs released (1,071) $ 35.74 RSUs cancelled (392) $ 42.61 Outstanding and unvested at April 30, 2023 12,064 $ 41.37
Summary of Stock-Based Compensation Expense	Total stock-based compensation expense recognized in the Company’s condensed consolidated statements of operations is as follows (in thousands): Three Months Ended April 30, 2023 2022 Cost of support $ 2,256 $ 1,959 Cost of cloud-hosted services 609 640 Cost of professional services and other 566 728 Sales and marketing 11,959 14,393 Research and development 11,731 14,738 General and administrative 13,042 13,801 Stock-based compensation expense, net of amounts capitalized $ 40,163 $ 46,259 Capitalized stock-based compensation 1,103 882 Total stock-based compensation expense $ 41,266 $ 47,141

Net Loss Per Share Attributab_2

Net Loss Per Share Attributable to Common Stockholders (Tables)	3 Months Ended
	Apr. 30, 2023
Earnings Per Share [Abstract]
Summary of Computation of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders	The following table sets forth the computation of basic and diluted net loss per share attributable to common stockholders (in thousands, except per share data): Three Months Ended April 30, 2023 2022 Numerator: Net loss $ (53,258) $ (78,217) Denominator: Weighted-average shares used to compute net loss per share attributable to Class A and Class B common stockholders, basic and diluted 190,806 182,948 Net loss per share attributable to Class A and Class B common stockholders, basic and diluted $ (0.28) $ (0.43)
Schedule of Antidilutive Securities Excluded from Computation of Diluted Net Loss Per Share	The following outstanding potentially dilutive shares of common stock were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented because the impact of including them would have been antidilutive (in thousands): Three Months Ended April 30, 2023 2022 Outstanding stock options and restricted stock units 20,868 24,646 Share purchase rights under the ESPP 1,999 947 Class A and Class B common stock subject to repurchase — 3 Total 22,867 25,596

Revenue and Performance Oblig_3

Revenue and Performance Obligations - Summary of Revenue Disaggregated by Category (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Disaggregation Of Revenue [Line Items]
Amount	$ 137,983	$ 100,897
% of Total Revenue | Product
Disaggregation Of Revenue [Line Items]
% of Total Revenue	100%	100%
Subscription Revenue
Disaggregation Of Revenue [Line Items]
Amount	$ 133,615	$ 98,384
Subscription Revenue | % of Total Revenue | Product
Disaggregation Of Revenue [Line Items]
% of Total Revenue	97%	98%
Subscription Revenue | License
Disaggregation Of Revenue [Line Items]
Amount	$ 15,158	$ 10,344
Subscription Revenue | License | % of Total Revenue | Product
Disaggregation Of Revenue [Line Items]
% of Total Revenue	11%	10%
Subscription Revenue | Support
Disaggregation Of Revenue [Line Items]
Amount	$ 101,913	$ 79,208
Subscription Revenue | Support | % of Total Revenue | Product
Disaggregation Of Revenue [Line Items]
% of Total Revenue	74%	79%
Subscription Revenue | Cloud-hosted services
Disaggregation Of Revenue [Line Items]
Amount	$ 16,544	$ 8,832
Subscription Revenue | Cloud-hosted services | % of Total Revenue | Product
Disaggregation Of Revenue [Line Items]
% of Total Revenue	12%	9%
Professional services and other
Disaggregation Of Revenue [Line Items]
Amount	$ 4,368	$ 2,513
Professional services and other | % of Total Revenue | Product
Disaggregation Of Revenue [Line Items]
% of Total Revenue	3%	2%

Revenue and Performance Oblig_4

Revenue and Performance Obligations - Summary of Revenue By Region Based On The Billing Address of Customers (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Revenues From External Customers And Long Lived Assets [Line Items]
Amount	$ 137,983	$ 100,897
% of Total Revenue | Region
Revenues From External Customers And Long Lived Assets [Line Items]
% of Total Revenue	100%	100%
United States
Revenues From External Customers And Long Lived Assets [Line Items]
Amount	$ 98,557	$ 72,791
United States | % of Total Revenue | Region
Revenues From External Customers And Long Lived Assets [Line Items]
% of Total Revenue	71%	72%
Rest of the world
Revenues From External Customers And Long Lived Assets [Line Items]
Amount	$ 39,426	$ 28,106
Rest of the world | % of Total Revenue | Region
Revenues From External Customers And Long Lived Assets [Line Items]
% of Total Revenue	29%	28%

Revenue and Performance Oblig_5

Revenue and Performance Obligations - Changes in Deferred Revenue and Unbilled Accounts Receivable (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Contract With Customer, Change In Contract With Customer, Asset, And Liability [Roll Forward]
Balance, beginning of period	$ 302,244	$ 223,289
Deferred revenue billings including reclassification to deferred revenue from customer deposits	113,046	98,094
Recognition of revenue, net of change in unbilled accounts receivable	(138,876)	(101,455)
Balance, end of period	276,414	219,928
* Reconciliation to revenue reported per consolidated statements of operations:
Revenue billed as of the end of the period	138,876	101,455
Increase (decrease) in total unbilled accounts receivable	(893)	(558)
Revenue reported per consolidated statements of operations	$ 137,983	$ 100,897

Revenue and Performance Oblig_6

Revenue and Performance Obligations - Additional information (Details) - USD ($) $ in Millions	3 Months Ended
	Apr. 30, 2023	Jan. 31, 2023
Disaggregation Of Revenue [Line Items]
Unbilled accounts receivable balance in due	1 year
Unbilled accounts receivable	$ 4	$ 4.9
Remaining performance obligations	$ 635.3	$ 647.1
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-02-01
Disaggregation Of Revenue [Line Items]
Remaining performance obligations, percentage		58%
Revenue remaining performance obligation, expected timing of satisfaction, period		12 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-05-01
Disaggregation Of Revenue [Line Items]
Remaining performance obligations, percentage	59%
Revenue remaining performance obligation, expected timing of satisfaction, period	12 months
Minimum
Disaggregation Of Revenue [Line Items]
Revenue, performance obligation, contract term	1 year
Maximum
Disaggregation Of Revenue [Line Items]
Revenue, performance obligation, contract term	3 years

Revenue and Performance Oblig_7

Revenue and Performance Obligations - Summary of Revenue Recognized Related to Customer Deposit Balance (Details) - USD ($) $ in Thousands	Apr. 30, 2023	Jan. 31, 2023
Disaggregation of Revenue [Abstract]
Within the next 12 months	$ 21,144	$ 22,657
After the next 12 months	3,746	4,042
Total	$ 24,890	$ 26,699

Short-Term Investments - Summar

Short-Term Investments - Summary of fair value of short-term investments (Details) $ in Thousands	Apr. 30, 2023 USD ($)
Debt Securities, Available-for-Sale [Line Items]
Amortized Cost	$ 322,459
Gross Unrealized Gains	221
Gross Unrealized Losses	(285)
Estimated Fair Value	322,395
U.S. treasury securities
Debt Securities, Available-for-Sale [Line Items]
Amortized Cost	182,660
Gross Unrealized Gains	44
Gross Unrealized Losses	(226)
Estimated Fair Value	182,478
U.S. agency obligations
Debt Securities, Available-for-Sale [Line Items]
Amortized Cost	46,327
Gross Unrealized Gains	134
Gross Unrealized Losses	(10)
Estimated Fair Value	46,451
Corporate notes and bonds
Debt Securities, Available-for-Sale [Line Items]
Amortized Cost	51,464
Gross Unrealized Gains	43
Gross Unrealized Losses	(49)
Estimated Fair Value	51,458
Commercial paper
Debt Securities, Available-for-Sale [Line Items]
Amortized Cost	28,992
Gross Unrealized Gains	0
Gross Unrealized Losses	0
Estimated Fair Value	28,992
Certificates of deposit
Debt Securities, Available-for-Sale [Line Items]
Amortized Cost	13,016
Gross Unrealized Gains	0
Gross Unrealized Losses	0
Estimated Fair Value	$ 13,016

Short-Term Investments - Narrat

Short-Term Investments - Narrative (Details)	Apr. 30, 2023 USD ($)
Investments, Debt and Equity Securities [Abstract]
Estimated Fair Value	$ 322,395,000
Allowance for expected credit losses	$ 0

Short-Term Investments - Summ_2

Short-Term Investments - Summary of contractual maturities (Details) $ in Thousands	Apr. 30, 2023 USD ($)
Amortized Cost
Due within one year	$ 270,424
Due after one year through three years	52,035
Amortized Cost	322,459
Fair Value
Due within one year	270,353
Due after one year through three years	52,042
Estimated Fair Value	$ 322,395

Fair Value Measurements - Sched

Fair Value Measurements - Schedule of Financial Assets Measured at Fair Value, By Level Within The Fair Value Hierarchy On A Recurring Basis (Details) - USD ($) $ in Thousands	Apr. 30, 2023	Jan. 31, 2023
Cash and Cash equivalents:
Cash and cash equivalents	$ 966,791	$ 1,286,134
Short-term investments:
Amortized Cost	322,459
Gross Unrealized Gains	221
Gross Unrealized Losses	(285)
Estimated Fair Value	322,395
U.S. treasury securities
Short-term investments:
Amortized Cost	182,660
Gross Unrealized Gains	44
Gross Unrealized Losses	(226)
Estimated Fair Value	182,478
U.S. agency obligations
Short-term investments:
Amortized Cost	46,327
Gross Unrealized Gains	134
Gross Unrealized Losses	(10)
Estimated Fair Value	46,451
Corporate notes and bonds
Short-term investments:
Amortized Cost	51,464
Gross Unrealized Gains	43
Gross Unrealized Losses	(49)
Estimated Fair Value	51,458
Commercial paper
Short-term investments:
Amortized Cost	28,992
Gross Unrealized Gains	0
Gross Unrealized Losses	0
Estimated Fair Value	28,992
Certificates of deposit
Short-term investments:
Amortized Cost	13,016
Gross Unrealized Gains	0
Gross Unrealized Losses	0
Estimated Fair Value	13,016
Fair Value, Recurring
Cash and Cash equivalents:
Amortized Cost	966,793
Gross Unrealized Gains	0
Gross Unrealized Losses	(2)
Cash and cash equivalents	966,791
Short-term investments:
Amortized Cost	322,459
Gross Unrealized Gains	221
Gross Unrealized Losses	(285)
Estimated Fair Value	322,395
Total asset measured at fair value, amortized cost	1,289,252
Total assets measured at fair value, gross unrealized gain	221
Total asset measured at fair value, gross unrealized loss	(287)
Total assets measured at fair value	1,289,186	169,904
Fair Value, Recurring | Cash
Cash and Cash equivalents:
Amortized Cost	863,524
Gross Unrealized Gains	0
Gross Unrealized Losses	0
Cash and cash equivalents	863,524
Level 1 | Fair Value, Recurring
Short-term investments:
Total assets measured at fair value		169,904
Level 1 | Fair Value, Recurring | Money market funds
Cash and Cash equivalents:
Amortized Cost	82,083
Gross Unrealized Gains	0
Gross Unrealized Losses	0
Cash and cash equivalents	82,083
Level 2 | Fair Value, Recurring
Short-term investments:
Total assets measured at fair value		$ 0
Level 2 | Fair Value, Recurring | U.S. treasury securities
Cash and Cash equivalents:
Amortized Cost	10,485
Gross Unrealized Gains	0
Gross Unrealized Losses	(2)
Cash and cash equivalents	10,483
Level 2 | Fair Value, Recurring | Corporate notes and bonds
Cash and Cash equivalents:
Amortized Cost	1,126
Gross Unrealized Gains	0
Gross Unrealized Losses	0
Cash and cash equivalents	1,126
Level 2 | Fair Value, Recurring | Commercial paper
Cash and Cash equivalents:
Amortized Cost	8,075
Gross Unrealized Gains	0
Gross Unrealized Losses	0
Cash and cash equivalents	8,075
Level 2 | Fair Value, Recurring | Certificates of deposit
Cash and Cash equivalents:
Amortized Cost	1,500
Gross Unrealized Gains	0
Gross Unrealized Losses	0
Cash and cash equivalents	1,500
Level 2 | Fair Value, Recurring | U.S. treasury securities
Short-term investments:
Amortized Cost	182,660
Gross Unrealized Gains	44
Gross Unrealized Losses	(226)
Estimated Fair Value	182,478
Level 2 | Fair Value, Recurring | U.S. agency obligations
Short-term investments:
Amortized Cost	46,327
Gross Unrealized Gains	134
Gross Unrealized Losses	(10)
Estimated Fair Value	46,451
Level 2 | Fair Value, Recurring | Corporate notes and bonds
Short-term investments:
Amortized Cost	51,464
Gross Unrealized Gains	43
Gross Unrealized Losses	(49)
Estimated Fair Value	51,458
Level 2 | Fair Value, Recurring | Commercial paper
Short-term investments:
Amortized Cost	28,992
Gross Unrealized Gains	0
Gross Unrealized Losses	0
Estimated Fair Value	28,992
Level 2 | Fair Value, Recurring | Certificates of deposit
Short-term investments:
Amortized Cost	13,016
Gross Unrealized Gains	0
Gross Unrealized Losses	0
Estimated Fair Value	$ 13,016

Fair Value Measurements - Sch_2

Fair Value Measurements - Schedule of Financial Assets Measured at Fair Value on a Recurring Basis (Details) - Fair Value, Recurring - USD ($) $ in Thousands	Apr. 30, 2023	Jan. 31, 2023
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total cash and cash equivalents		$ 169,904
Total assets measured at fair value	$ 1,289,186	169,904
Money market funds
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total cash and cash equivalents		169,904
Level 1
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total cash and cash equivalents		169,904
Total assets measured at fair value		169,904
Level 1 | Money market funds
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total cash and cash equivalents		169,904
Level 2
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total cash and cash equivalents		0
Total assets measured at fair value		0
Level 2 | Money market funds
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total cash and cash equivalents		0
Level 3
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total cash and cash equivalents		0
Total assets measured at fair value		0
Level 3 | Money market funds
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Total cash and cash equivalents		$ 0

Fair Value Measurements - Addit

Fair Value Measurements - Additional Information (Details)	Apr. 30, 2023 USD ($)
Fair Value Disclosures [Abstract]
Fair value measurement, transfers level 1 to level 2	$ 0

Balance Sheet Components - Summ

Balance Sheet Components - Summary of Other Assets Non-current (Details) - USD ($) $ in Thousands	Apr. 30, 2023	Jan. 31, 2023
Other Assets, Noncurrent [Abstract]
Property and equipment, net	$ 27,244	$ 24,594
Operating lease right-of-use assets	11,827	12,560
Other	2,171	902
Total other assets, non-current	$ 41,242	$ 38,056

Balance Sheet Components - Su_2

Balance Sheet Components - Summary of Property and Equipment Net (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2023	Jan. 31, 2023
Property Plant And Equipment [Line Items]
Total property and equipment	$ 37,107	$ 32,875
Less: accumulated depreciation and amortization	(9,863)	(8,281)
Property and equipment, net	$ 27,244	24,594
Furniture and fixtures
Property Plant And Equipment [Line Items]
Estimated Useful life	5 years
Total property and equipment	$ 1,330	1,292
Computers, equipment and software
Property Plant And Equipment [Line Items]
Estimated Useful life	3 years
Total property and equipment	$ 581	581
Capitalized internal-use software development costs
Property Plant And Equipment [Line Items]
Estimated Useful life	5 years
Total property and equipment	$ 29,635	25,817
Leasehold improvements
Property Plant And Equipment [Line Items]
Estimated Useful life	Shorter of useful life or lease term
Total property and equipment	$ 5,484	5,138
Construction in progress
Property Plant And Equipment [Line Items]
Total property and equipment	$ 77	$ 47

Balance Sheet Components - Addi

Balance Sheet Components - Additional Information (Details) - USD ($)	3 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Supplemental Balance Sheet Disclosures [Abstract]
Depreciation and amortization expense	$ 1,600,000	$ 900,000
Software capitalized costs	3,800,000	2,500,000
Amortization of capitalized costs	1,300,000	600,000
Impairment losses for deferred contract acquisition costs	$ 0	$ 0

Balance Sheet Components - Su_3

Balance Sheet Components - Summary of Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands	Apr. 30, 2023	Jan. 31, 2023
Payables and Accruals [Abstract]
Accrued expenses	$ 3,013	$ 4,222
Operating lease liabilities	3,488	3,380
Accrued income taxes payable	991	1,081
Sales tax payable	1,343	1,480
Total accrued expenses and other current liabilities	$ 8,835	$ 10,163

Balance Sheet Components - Accr

Balance Sheet Components - Accrued Compensation and Benefits (Details) - USD ($) $ in Thousands	Apr. 30, 2023	Jan. 31, 2023
Compensation And Benefits [Abstract]
Accrued commissions	$ 9,876	$ 16,932
Accrued vacation	22,557	20,614
Accrued payroll and withholding taxes	8,361	11,574
ESPP employee contributions	9,432	4,247
Accrued bonus	2,729	3,220
Other	519	2,041
Total accrued compensation and benefits	$ 53,474	$ 58,628

Balance Sheet Components - Su_4

Balance Sheet Components - Summary of Activity of Deferred Contract Acquisition Costs (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Capitalized Contract Cost, Net, Classified [Roll Forward]
Beginning balance	$ 124,098	$ 89,331
Capitalization of contract acquisition costs	11,663	15,212
Amortization of deferred contract acquisition costs	(12,539)	(9,138)
Ending balance	123,222	95,405
Deferred contract acquisition costs, current	42,995	32,200
Deferred contract acquisition costs, non-current	80,227	63,205
Total deferred contract acquisition costs	$ 123,222	$ 95,405

Balance Sheet Components - Sche

Balance Sheet Components - Schedule of Other Liabilities, Non-current (Details) - USD ($) $ in Thousands	Apr. 30, 2023	Jan. 31, 2023
Supplemental Balance Sheet Disclosures [Abstract]
Operating lease liabilities, non-current	$ 11,178	$ 12,093
Accrued commissions	792	713
Total other liabilities, non-current	$ 11,970	$ 12,806

Leases - Schedule of Lease Cost

Leases - Schedule of Lease Costs (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Leases [Abstract]
Short-term lease costs	$ 156	$ 100
Operating lease costs	878	878
Total lease costs	$ 1,034	$ 978

Leases - Summary of Lease Term

Leases - Summary of Lease Term and Discount Rate (Details)	Apr. 30, 2023
Leases [Abstract]
Weighted average remaining lease terms (in years)	3 years 10 months 24 days
Weighted average discount rate	3.80%

Leases - Schedule of Future Lea

Leases - Schedule of Future Lease Payments (Details) - USD ($) $ in Thousands	Apr. 30, 2023	Jan. 31, 2023
Leases [Abstract]
2024 (remaining nine months)	$ 2,961
2025	4,150
2026	3,734
2027	3,737
2028	1,277
Total minimum lease payments	15,859
Less imputed interest	(1,193)
Present value of future minimum lease payments	14,666
Less current lease liabilities	(3,488)	$ (3,380)
Operating lease liabilities, non-current	$ 11,178	$ 12,093

Leases - Additional Information

Leases - Additional Information (Details) - USD ($)	3 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Leases [Abstract]
Operating right-of-use asset impairment losses	$ 0	$ 0

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Details) - USD ($) $ in Millions	Apr. 30, 2023	Jan. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Letters of credit outstanding amount	$ 1.8	$ 1.8

Common Stock and Stockholders_3

Common Stock and Stockholders' Equity - Schedule of Reserved Shares of Common Stock for Future Issuance (Details) - shares shares in Thousands	Apr. 30, 2023	Jan. 31, 2023
Class Of Stock [Line Items]
Common stock capital shares reserved for future issuance	55,191	45,377
2021 Equity Incentive Plan
Class Of Stock [Line Items]
Remaining shares available for future issuance	29,419	21,466
2021 Employee Stock Purchase Plan ("ESPP")
Class Of Stock [Line Items]
Common stock capital shares reserved for future issuance	4,907	3,008
Options outstanding
Class Of Stock [Line Items]
Common stock capital shares reserved for future issuance	8,801	9,315
Restricted stock units outstanding
Class Of Stock [Line Items]
Common stock capital shares reserved for future issuance	12,064	11,588

Common Stock and Stockholders_4

Common Stock and Stockholders' Equity - Schedule of Stock Option Activity (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		12 Months Ended
	Apr. 30, 2023	Apr. 30, 2022	Jan. 31, 2023
Aggregate Intrinsic Value
Aggregate intrinsic value, excercised	$ 14,700	$ 34,800
2021 Equity Incentive Plan
Number of Options Outstanding
Beginning balance (in shares)	9,315
Stock options exercised (in shares)	(513)
Stock options cancelled/forfeited/expired (in shares)	(1)
Ending balance (in shares)	8,801		9,315
Number of options outstanding, exercisable (in shares)	8,678
Weighted-Average Grant Date Fair Value
Beginning balance (in dollars per share)	$ 1.92
Stock options exercised (in dollars per share)	1.98
Stock options cancelled/forfeited/expired (in dollars per share)	5.70
Ending balance (in dollars per share)	1.92		$ 1.92
Weighted-average exercise price per share, exercisable (in dollars per share)	$ 1.77
Weighted- Average Remaining Contractual Term (in Years)	4 years 6 months		4 years 7 months 6 days
Weighted Average Remaining Contractual Term, Exercisable (in years)	4 years 4 months 24 days
Aggregate Intrinsic Value
Aggregate intrinsic value	$ 219,062		$ 281,837
Aggregate intrinsic value, excercised	14,679
Aggregate intrinsic value, exercisable	$ 217,340

Common Stock and Stockholders_5

Common Stock and Stockholders' Equity - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2023	Apr. 30, 2022	Jan. 31, 2023
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Total grant-date fair value of stock options vested	$ 500	$ 1,300
Total intrinsic value of options exercised	14,700	34,800
Stock-based compensation expense, net of amounts capitalized	40,163	46,259
Unrecognized stock-based compensation expense	$ 900	$ 4,000
Unrecognized stock-based compensation expense, weighted-average period	1 year 2 months 12 days	1 year 6 months
ESPP employee payroll contributions	$ 53,474		$ 58,628
2021 Equity Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Total intrinsic value of options exercised	$ 14,679
Number of shares available for sale	29,419,000		21,466,000
2021 Employee Stock Purchase Plan ("ESPP")
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock-based compensation expense, net of amounts capitalized	$ 3,000	$ 3,100
Unrecognized stock-based compensation expense	$ 19,000
Unrecognized stock-based compensation expense, weighted-average period	1 year 7 months 6 days
ESPP employee payroll contributions	$ 9,400
2021 Employee Stock Purchase Plan ("ESPP") | Common Class A
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of shares available for sale	4,907,132
Restricted Stock Units
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Grant-date fair value of vested shares	$ 38,300	17,500
Unrecognized stock-based compensation expense	$ 359,500	$ 420,600
Unrecognized stock-based compensation expense, weighted-average period	2 years 10 months 24 days	3 years 1 month 6 days

Common Stock and Stockholders_6

Common Stock and Stockholders' Equity - Schedule of Restricted Stock Units (RSUs") Activity (Details) - 2014 and 2021 Plans - Restricted Stock Units shares in Thousands	3 Months Ended
	Apr. 30, 2023 $ / shares shares
Number of Awards
Beginning balance (in shares) | shares	11,588
RSUs granted (in shares) | shares	1,939
RSUs released (in shares) | shares	(1,071)
RSUs cancelled (in shares) | shares	(392)
Ending balance (in shares) | shares	12,064
Weighted-Average Grant Date Fair Value
Beginning balance (in dollars per share) | $ / shares	$ 42.48
RSUs granted (in dollars per share) | $ / shares	31.89
RSUs released (in dollars per share) | $ / shares	35.74
RSUs cancelled (in dollars per share) | $ / shares	42.61
Ending balance (in dollars per share) | $ / shares	$ 41.37

Common Stock and Stockholders_7

Common Stock and Stockholders' Equity - Summary of Stock-Based Compensation Expense (Details) - USD ($)	3 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Stock-based compensation expense:
Stock-based compensation expense, net of amounts capitalized	$ 40,163,000	$ 46,259,000
Capitalized stock-based compensation	1,103,000	882,000
Total stock-based compensation expense	41,266,000	47,141,000
Cost Of Revenue | Support
Stock-based compensation expense:
Stock-based compensation expense, net of amounts capitalized	2,256,000	1,959,000
Cost Of Revenue | Cloud-hosted services
Stock-based compensation expense:
Stock-based compensation expense, net of amounts capitalized	609,000	640,000
Cost Of Revenue | Professional services and other
Stock-based compensation expense:
Stock-based compensation expense, net of amounts capitalized	566,000	728,000
Sales and marketing
Stock-based compensation expense:
Stock-based compensation expense, net of amounts capitalized	11,959,000	14,393,000
Research and development
Stock-based compensation expense:
Stock-based compensation expense, net of amounts capitalized	11,731,000	14,738,000
General and administrative
Stock-based compensation expense:
Stock-based compensation expense, net of amounts capitalized	$ 13,042,000	$ 13,801,000

Net Loss Per Share Attributab_3

Net Loss Per Share Attributable to Common Stockholders - Additional Information (Details)	3 Months Ended
	Apr. 30, 2023 vote
Class A Common Stock
Class Of Stock [Line Items]
Common stock, voting rights	1
Class B Common Stock
Class Of Stock [Line Items]
Common stock, voting rights	10

Net Loss Per Share Attributab_4

Net Loss Per Share Attributable to Common Stockholders - Summary of Computation of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Numerator:
Net loss	$ (53,258)	$ (78,217)
Denominator:
Weighted-average shares used to compute net loss per share attributable to Class A and Class B common stockholders, basic (in shares)	190,806	182,948
Weighted-average shares used to compute net loss per share attributable to Class A and Class B common stockholders, diluted (in shares)	190,806	182,948
Net loss per share attributable to Class A and Class B common stockholders, basic (in dollars per share)	$ (0.28)	$ (0.43)
Net loss per share attributable to Class A and Class B common stockholders, diluted (in dollars per share)	$ (0.28)	$ (0.43)

Net Loss Per Share Attributab_5

Net Loss Per Share Attributable to Common Stockholders - Schedule of Antidilutive Securities Excluded from Computation of Diluted Net Loss Per Share (Details) - shares shares in Thousands	3 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share	22,867	25,596
Outstanding stock options and restricted stock units
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share	20,868	24,646
Share purchase rights under the ESPP
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share	1,999	947
Class A and Class B common stock subject to repurchase
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share	0	3

Subsequent Events (Details)

Subsequent Events (Details) - Subsequent event $ in Millions	Jun. 07, 2023 USD ($)
Subsequent Event [Line Items]
Workforce reduction plan, percentage of people impacted	8%
Workforce reduction plan, reduction in current annualized payroll and benefit expenses	$ 36
Minimum
Subsequent Event [Line Items]
Workforce reduction plan, expected charges	7.5
Maximum
Subsequent Event [Line Items]
Workforce reduction plan, expected charges	$ 9